Skip to content

Dr. David Strybol

Active
Private limited companyfounded 20188 yrs activeLuikerlaan 18, 3400 Landen, BelgiumKBO/BCE: BE 0687.585.191

Dr. David Strybol has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €195k and a net result of €217k. Equity is growing by ~32.1% per year across the filed fiscal years. Its solvency ranks better than 36% of 16491 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
79 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency71▼-29
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €15k at 30 days acceptable
Liquidity ample (current ratio 1.66 against 20.12 in 2024; short-term debt: 53.7% and cash: 12.5% of total assets), but 53.7% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
46.3%
Return on assets
51.6%
Age of the figures
15 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 8 years 0 10 y
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 12-12-2025, 50 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
50 d early
2024
2 d early
2023
on the day
2022
5 d early
2021
27 d early
2020
26 d early
2019
on the day
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-06-2026 close19-09-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€195k▼ 45.1%
2024 · €355k
2019: €42k 2020: €105k 2021: €188k 2022: €378k 2023: €343k 2024: €355k
2019 → 2025
Total assets
€421k▲ 13.8%
2024 · €370k
2019: €104k 2020: €160k 2021: €224k 2022: €405k 2023: €360k 2024: €370k
2019 → 2025
Net result
€217k▲ 35.4%
2024 · €160k
2019: €30k 2020: €63k 2021: €83k 2022: €189k 2023: €148k 2024: €160k
2019 → 2025
Working capital
€148k▼ 48.3%
2024 · €287k
2019: €30k 2020: €75k 2021: €139k 2022: €282k 2023: €264k 2024: €287k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€188k-€378k▲ 101%€343k▼ 9.2%€355k▲ 3.4%€195k▼ 45.1%
Operating result€116k-€247k▲ 113%€193k▼ 21.7%€207k▲ 7.2%€281k▲ 35.8%
Net result€83k-€189k▲ 128%€148k▼ 21.7%€160k▲ 7.9%€217k▲ 35.4%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200k€300kOperating result 2021: €116k€116kNet result 2021: €83k€83kOperating result 2022: €247k€247kNet result 2022: €189k€189kOperating result 2023: €193k€193kNet result 2023: €148k€148kOperating result 2024: €207k€207kNet result 2024: €160k€160kOperating result 2025: €281k€281kNet result 2025: €217k€217k20212022202320242025
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 36% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €421k
Fixed assets €46k▼ 31.9%
Current assets €374k▲ 24.1%
Equity and liabilities €421k
Equity €195k▼ 45.1%
Debt €226k▲ 1,408%
The debt ratio rises from 4.1% to 53.7%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€304k
2024 · €229k
Cash flow
€240k
2024 · €182k
Solvency
46.3%
2024 · 95.9%
Current ratio
1.66
2024 · 20.12
Quick ratio
1.66
2024 · 20.12
Debt / equity
1.16
2024 · 0.04
ROE
111.5%
2024 · 45.1%
ROA
51.6%
2024 · 43.3%
Interest coverage
2174.49
2024 · 505.37
Debt
€226k
2024 · €15k
Debt ≤ 1 year
€226k
2024 · €15k
Income taxes
€67k
2024 · €48k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€370k€421k
Fixed assets21/28€68k€46k
Tangible fixed assets22/27€68k€46k
Land and buildings22€20k€16k
Plant, machinery and equipment23€2k€787
Furniture and vehicles24€44k€29k
Assets under construction and advance payments27€2k-
Current assets29/58€302k€374k
Amounts receivable within one year40/41€103k€110k
Trade receivables40€101k€110k
Other amounts receivable41€2k-
Current investments50/53€100k€210k
Cash at bank and in hand54/58€94k€53k
Deferred charges and accrued income490/1€4k€1k
Equity and liabilities
Total equity and liabilities10/49€370k€421k
Equity10/15€355k€195k
Contributions10/11€19k€19k=
Reserves13€335k€175k
Distributable reserves133€335k€175k
Profit (loss) carried forward14€719€719=
Amounts payable17/49€15k€226k
Amounts payable within one year42/48€15k€226k
Trade debts44€10k€4k
Suppliers440/4€10k€4k
Taxes, remuneration and social security45-€980
Taxes450/3-€980
Other amounts payable47/48€5k€221k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€22k€23k
Other operating charges640/8€263€272
Gross operating margin9900€229k€305k
Operating profit (loss)9901€207k€281k
Financial income75/76B€2k€3k
Recurring financial income75€2k€3k
Financial charges65/66B€453€140
Recurring financial charges65€453€140
Profit (loss) for the period before taxes9903€209k€284k
Income taxes67/77€48k€67k
Profit (loss) for the period9904€160k€217k
Profit (loss) for the period to be appropriated9905€160k€217k
Appropriation of the result
Profit (loss) to be appropriated9906€161k€218k
Profit (loss) brought forward from the previous period14P€719€719=
Transfer from equity791/2€148k€160k
Transfer to equity691/2€160k-
To other reserves6921€160k-
Profit to be distributed694/7€148k€377k
Return on contributions (dividend)694€148k€377k

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-01-2027
2025
12-12
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
30-06
Financial Highest result since 2019net €217k ▲35.4%
Operating result €281k, net result €217k, both a record.
29-01
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-01
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
26-01
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
30-06
Financial Liquidity doublescurrent ratio 11.55
Current ratio from 4.90 to 11.55; short-term debt falls from €36k to €27k.
30-06
Financial Equity above €200kEq €378k ▲101%
4 profitable years in a row build equity to €378k.
04-01
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
30-06
Financial Equity above €150kEq €188k ▲79.1%
3 profitable years in a row build equity to €188k.
05-01
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
30-06
Financial Equity above €100kEq €105k ▲151%
2 profitable years in a row build equity to €105k.
31-01
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Landen · 1 establishment unit since 2018
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Luikerlaan 183400 Landen
Ground area
1,302 m²
Building footprint
175 m²
Volume, LiDAR
98 m³
Parcel 24059A1053/00H004, Flanders · tallest building 2.7 m. Linked by address, not a title deed.
1 establishment unit
Luikerlaan 18, 3400 Landen
Specialist medical practice
since 20182.272.080.488
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24059A1053/00H004 Flanders 1,302 m² 1 · 175 m² 2.6 m
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,627 companies in sector 86220 we hold annual accounts for 7,973. 6,731 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded05-01-2018
Fiscal year end30-06
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers

Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.